Novavax, Inc. (NVAX)
6.785
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 13:34
Novavax EPS Diluted (Quarterly): -1.246 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Moderna, Inc. | -0.5128 |
| Merck & Co., Inc. | 2.316 |
| Sangamo Therapeutics, Inc. | -0.1148 |
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -202.38M |
| Revenue (Quarterly) | 70.44M |
| Total Expenses (Quarterly) | 272.82M |
| Enterprise Value | 579.17M |
| Gross Profit Margin (Quarterly) | 71.90% |
| Profit Margin (Quarterly) | -287.3% |
| Earnings Yield | 26.07% |
| Operating Earnings Yield | 36.27% |
| Normalized Earnings Yield | 34.81 |